SmartTRAK is excited to be attending #SNIS - Society of Neuro Interventional Surgery's 15th annual meeting on July 23-26 at the Hilton San Francisco Union Square, in San Francisco, California.SmartTRAK will be represented by Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies and Christopher McCarthy, Vice President Corporate Accounts, Orthopedics and Neuro. Please contact us if you would like a meeting.
Among the many topics covered in the full Q118 SCS Market Recap are:
In May 2017, Nevro CEO Rami Elghandour chatted with Anne Staylor, BioMedGPS Managing Editor/Neuro Analyst to discuss dynamics in the global spinal cord stimulation (SCS) market, including trends, drivers, challenges, competition, and opportunity that would influence the Company’s growth.
A fascinating read then, that now has us appraising a year later if Elghandour's expansion predictions came to pass. Is Nevro still the one to beat as the top leader in the neuromodulation field?
Medtronic’s Stacey Pugh discusses the Company’s new Riptide Aspiration System, new products in development, and growth strategies for the neurovascular business in a podcast interview with SmartTRAK at the International Stroke Conference (ISC) 2018 held Jan. 24-26, 2018 in Los Angeles, CA.
Anne Staylor here with BioMedGPS. We're at the International Stroke Conference in Los Angeles, and today I'm talking with Stacey Pugh of Medtronic Neurovascular. Hi Stacey, thanks for joining me.
In the market for stroke devices, Europe seems to be the proving ground for next generation devices, and several companies with novel technologies are emerging from Europe that could potentially reach the US market in the next several years. One European company taking aim at the US market is Bochum, Germany-based phenox GmbH.
SmartTRAK is excited to be attending LINNC Paris 2018 on June 11-13, 2018, at the Carrousel du Louvre, Paris, France.Attending the meeting representing SmartTRAK will be Anne Staylor , Managing Editor, Business Intelligence and Senior Director, Advanced Technologies.
The US Spinal Cord Stimulation market reached new heights in Q417/FY17, driven by new products, expanding indications, and a growing demand for non-narcotic alternatives for treating chronic intractable pain.SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Spinal Cord Stimulation Market Recap and Financial Dashboard.
Among the many topics covered in the Q417/FY17 Spinal Cord Stimulation Market Recap are:
Topics: SmartTRAK Conferences
Scott Drees, CEO of Nuvectra Corporation, discusses the Company’s challenges and opportunities in 2017, strategies for driving growth and market penetration in neuromodulation, and the Company’s key priorities for 2018 in an interview with SmartTRAK at the North American Neuromodulation Society Annual Meeting held Jan. 11-14, 2018 in Las Vegas, NV.
A transcript of SmartTRAK’s interview with Scott Drees is below, or click the following video to view the interview recorded live at NANS 2018. (17:41 minutes.)
SmartTRAK is excited to be attending #ISC 2018 - International Stroke Conference, January 24-26 at the Los Angeles Convention Center.
The International Stroke Conference is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease.